ZS/DC P013 dendritic cell vaccine (Zhongsheng Kangyuan)

N/A

Report date: 2024/08/29 14:00:42

Base Information

Drug NameZS/DC P013 dendritic cell vaccine (Zhongsheng Kangyuan)
Drug Alias NameZS/DC_P-013
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhongsheng Kangyuan Biotechnology (Beijing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhongsheng Kangyuan Biotechnology (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A